| Q35654770 | 11. Cancers attributable to infection in the UK in 2010. |
| Q37147418 | A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety |
| Q26777111 | A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers |
| Q35025767 | A Review of Carcinomas Arising in the Head and Neck Region in HIV-Positive Patients |
| Q53692324 | A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda. |
| Q40500774 | A cross-sectional population-based study of breast cancer screening among women with HIV in Ontario, Canada |
| Q34612071 | A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals |
| Q47349846 | A randomized, controlled pilot study of warm handoff versus fax referral for hospital-initiated smoking cessation among people living with HIV/AIDS. |
| Q34135803 | A review of the application of inflammatory biomarkers in epidemiologic cancer research |
| Q22241462 | AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy |
| Q37280653 | AIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach |
| Q59621919 | AIDS-associated malignancies |
| Q80510580 | AIDS-associated malignancies |
| Q34541712 | AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? |
| Q34636933 | AIDS-related cancer and severity of immunosuppression in persons with AIDS. |
| Q36546891 | Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy |
| Q38000538 | Actinic cheilitis and squamous cell carcinoma of the lip: clinical, histopathological and immunogenetic aspects |
| Q91725648 | Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base |
| Q34766695 | Age at Cancer Diagnosis Among Persons With AIDS in the United States |
| Q22251046 | Aids-related malignancies |
| Q36074472 | An ecological approach to examine lung cancer disparities due to sexual orientation |
| Q47592792 | Anal Cancer Risk Among People With HIV Infection in the United States |
| Q35174165 | Anal cancer: an HIV-associated cancer |
| Q37037858 | Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women |
| Q37257528 | Antihypertensive drugs and lip cancer in non-Hispanic whites |
| Q36103167 | Approach to the treatment of cutaneous malignancy in HIV-infected patients |
| Q28481666 | Associations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profiles |
| Q36050334 | Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations |
| Q37023708 | Biology of human papillomavirus-related oropharyngeal cancer |
| Q34267809 | Blood transfusions and the subsequent risk of hematologic malignancies |
| Q36889493 | Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study |
| Q89820652 | Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D |
| Q37800491 | Breast Cancer in Women with Human Immunodeficiency Virus Infection: Pathological, Clinical, and Prognostic Implications |
| Q35026128 | Breast Cancer in the Setting of HIV |
| Q37816497 | Breast cancer and HIV in the era of highly active antiretroviral therapy: two case reports and review of the literature |
| Q36997747 | Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa |
| Q79132079 | Breast cancer in HIV positive women: a report of four cases and review of the literature |
| Q35009307 | Breast cancer in women with human immunodeficiency virus infection: implications for diagnosis and therapy |
| Q42027539 | CD4 Count and Anti Retroviral Therapy for HIV Positive Patients With Cancer in Nigeria -A Pilot Study |
| Q36745251 | CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection |
| Q88336925 | CHAPTER 5 HPV infection and HPV-associated neoplasia in immunocompromised women |
| Q41335286 | Cancer Treatment in Patients With HIV Infection and Non-AIDS-Defining Cancers: A Survey of US Oncologists |
| Q37617925 | Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study |
| Q34916327 | Cancer burden in the HIV-infected population in the United States |
| Q38810027 | Cancer care disparities in people with HIV in the United States. |
| Q35801613 | Cancer in HIV-infected persons from the Caribbean, Central and South America |
| Q37763574 | Cancer in cohort of HIV-infected population: prevalence and clinical characteristics |
| Q41055765 | Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies |
| Q37717137 | Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009. |
| Q34348772 | Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007 |
| Q35842459 | Cancer of the penis associated with HIV: a report of three cases presenting at the CHU cocody, ivory coast |
| Q58739954 | Cancer prevention in patients with human immunodeficiency virus infection |
| Q37515370 | Cancer risk in HIV-infected persons: influence of CD4(+) count |
| Q47555135 | Cancer risk in older people living with human immunodeficiency virus infection in the United States. |
| Q37154598 | Cancer risk in persons with HIV/AIDS in India: a review and future directions for research |
| Q34403321 | Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy |
| Q35838509 | Cancer screening in patients infected with HIV. |
| Q39752084 | Cancer survivorship and sexual orientation |
| Q33927996 | Cancer treatment disparities in HIV-infected individuals in the United States |
| Q36502616 | Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD). |
| Q36643922 | Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma |
| Q34481581 | Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors |
| Q28389988 | Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy |
| Q35073897 | Cerebral Metastasis from Breast Cancer in a Male Patient with HIV. |
| Q37196823 | Cerebro-meningeal infections in HIV-infected patients: a study of 116 cases in Libreville, Gabon |
| Q37426394 | Changing Patterns of lung, liver, and head and neck non-AIDS-defining cancers relative to HIV status in Tanzania between 2002-2014. |
| Q40617146 | Characteristics and survival of patients with non-Hodgkin's lymphoma with and without acquired immunodeficiency syndrome |
| Q34477550 | Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions |
| Q33710567 | Circulating serum free light chains as predictive markers of AIDS-related lymphoma |
| Q99362785 | Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma |
| Q38907381 | Clinical and computed tomography findings in Chinese lung cancer patients with HIV infection: A multi-center study |
| Q45363289 | Clinical characteristics of Japanese lung cancer patients with human immunodeficiency virus infection. |
| Q38664912 | Clinical management of HIV-associated hematologic malignancies |
| Q38348630 | Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study |
| Q38186139 | Colorectal and anal cancer in HIV/AIDS patients: a comprehensive review |
| Q38489954 | Colorectal cancer among persons with HIV: protocol for a systematic review and meta-analysis |
| Q37697520 | Colorectal cancer and immunity: what we know and perspectives |
| Q44088200 | Colorectal cancer in HIV-infected patients: a case control study |
| Q36960567 | Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection |
| Q38513316 | Colorectal cancer screening in HIV-infected patients 50 years of age and older: missed opportunities for prevention |
| Q34643410 | Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States |
| Q36417071 | Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans |
| Q34103593 | Dendritic cells: key players in human herpesvirus 8 infection and pathogenesis |
| Q33945721 | Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation |
| Q40049499 | Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model system |
| Q24817164 | Differential gene expression in HIV/SIV-associated and spontaneous lymphomas |
| Q35067667 | Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry |
| Q37233212 | Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? |
| Q38081246 | Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma? |
| Q58883405 | Does HIV Infection Independently Increase the Incidence of Lung Cancer? |
| Q36671434 | Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? |
| Q42538517 | Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers? |
| Q45063752 | Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study |
| Q33789114 | Effect of early versus deferred antiretroviral therapy for HIV on survival |
| Q39227230 | Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. |
| Q35009761 | Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma |
| Q27000028 | Epidemic of lung cancer in patients with HIV infection |
| Q37381789 | Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. |
| Q33920125 | Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin |
| Q57008100 | Epidemiological and Clinical Characteristics of HIV Infected Patients at a Tertiary Care Hospital in Oman |
| Q59211733 | Epidemiology |
| Q35174119 | Epidemiology of AIDS-related malignancies an international perspective |
| Q35122830 | Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma |
| Q98460335 | Epidemiology of haematological malignancies in people living with HIV |
| Q27023830 | Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines |
| Q35062377 | Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. |
| Q37309589 | Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. |
| Q37427561 | Epidermoid carcinoma of the anal canal |
| Q34396787 | Etiologic factors in testicular germ-cell tumors |
| Q37003547 | Etiologic heterogeneity among non-Hodgkin lymphoma subtypes |
| Q37353390 | Evolving spectrum and incidence of non-AIDS-defining malignancies |
| Q36036666 | Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons |
| Q37666176 | Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma |
| Q36353396 | Genital human papillomavirus infection in men. |
| Q36655162 | HIV and aging: implications for patient management |
| Q33595338 | HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India |
| Q37246654 | HIV and prostate cancer: a systematic review of the literature |
| Q33533549 | HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study |
| Q33827510 | HIV infection and the risk of cancers with and without a known infectious cause |
| Q35086332 | HIV infection in the elderly |
| Q35095062 | HIV infection in the etiology of lung cancer: confounding, causality, and consequences |
| Q33834602 | HIV infection is associated with an increased risk for lung cancer, independent of smoking |
| Q28744167 | HIV tropism and decreased risk of breast cancer |
| Q58773583 | HIV-1 Envelope Protein gp120 Promotes Proliferation and the Activation of Glycolysis in Glioma Cell |
| Q41918626 | HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness. |
| Q38929261 | HIV-Associated Lung Cancer |
| Q59152803 | HIV-Infected Patients With Anal Carcinoma Who Subsequently Developed Oral Squamous Cell Carcinoma: Report of 2 Cases |
| Q33602854 | HIV-K: an integrative knowledge base for semantic integration of AIDS-related malignancy data and treatment outcomes. |
| Q37005958 | HIV-associated Kaposi sarcoma and gender |
| Q37351970 | HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management. |
| Q42282227 | HIV-associated lung cancer: survival in an unselected cohort |
| Q34844389 | HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies |
| Q34978561 | HIV/AIDS and Colorectal Cancer: A Review in the Era of Antiretrovirals |
| Q35623688 | HPV Infection in a Cohort of HIV-Positive Men and Women: Prevalence of Oncogenic Genotypes and Predictors of Mucosal Damage at Genital and Oral Sites |
| Q33885571 | Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations |
| Q36668229 | Hepatocellular cancer in HIV-infected individuals: tomorrow's problem? |
| Q37288434 | High cancer-related mortality in an urban, predominantly African-American, HIV-infected population |
| Q33593553 | High prevalence of malignancy in HIV-positive patients with mediastinal lymphadenopathy: a study in the era of antiretroviral therapy |
| Q45173051 | High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. |
| Q48620344 | History of allergies and autoimmune diseases and risk of brain tumors in adults |
| Q40475089 | History of allergies and risk of glioma in adults. |
| Q24685909 | Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS |
| Q44649503 | Hospitalization for Inflammatory Bowel Disease is Associated with Increased Risk of Breast Cancer: A Nationwide Cohort Study of an Asian Population |
| Q35103531 | How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus |
| Q33574329 | Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful |
| Q92712473 | Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth |
| Q36897143 | Human immunodeficiency virus-associated lung malignancies |
| Q44667547 | Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study |
| Q37176664 | Human papillomavirus and anal neoplasia |
| Q28069930 | Human papillomavirus and gastrointestinal cancer: A review |
| Q37587903 | Human papillomavirus infections in nonsexually active perinatally HIV infected children |
| Q58567172 | Human papillomavirus prevalence and behavioral risk factors among HIV-infected and HIV-uninfected men who have sex with men in Taiwan |
| Q33425662 | Human papillomavirus-related disease in people with HIV |
| Q34195916 | Imaging lung manifestations of HIV/AIDS. |
| Q35174130 | Immune reconstitution in HIV infection and its relationship to cancer |
| Q45998465 | Immune reconstitution inflammatory syndrome presenting as superior vena cava syndrome secondary to Coccidioides lymphadenopathy in an HIV-infected patient. |
| Q58280974 | Immunity, infection, and cancer |
| Q33987654 | Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients |
| Q36727400 | Impact of the HIV epidemic on the incidence rates of anal cancer in the United States |
| Q37710115 | Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study |
| Q36908566 | Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals |
| Q30482915 | Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals |
| Q33651611 | Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study |
| Q38124683 | Incidence and risk of lung cancer in HIV-infected patients |
| Q34580943 | Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis |
| Q36671382 | Incidence of malignant neoplasms among HIV-infected persons in Scotland. |
| Q33624504 | Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression |
| Q33835631 | Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients |
| Q36004602 | Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology |
| Q34535134 | Increased risk of stomach and esophageal malignancies in people with AIDS. |
| Q43897862 | Infectious complications of cancer chemotherapy in HIV patients |
| Q38017050 | Kaposi sarcoma: review and medical management update |
| Q38038176 | Lessons from cancer immunoediting in cutaneous melanoma |
| Q22252510 | Lifestyle-related factors and environmental agents causing cancer: An overview |
| Q37095824 | Long-term incidence of cervical cancer in women with human immunodeficiency virus |
| Q37367141 | Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010. |
| Q37794674 | Lung Cancer in HIV-Positive Patients |
| Q35667193 | Lung cancer in HIV Infection. |
| Q36237964 | Lung cancer in HIV infected patients: facts, questions and challenges. |
| Q26769769 | Lung cancer in HIV-infected patients in the combination antiretroviral treatment era |
| Q35687567 | Lung cancer in patients with HIV infection: is it AIDS-related? |
| Q42425270 | Lymphoma in HIV patients: Varied presentations |
| Q47886730 | Malignancies in HIV-Infected and AIDS Patients |
| Q35850380 | Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges |
| Q37346149 | Malignancies in women with HIV infection |
| Q34332052 | Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy |
| Q37429108 | Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). |
| Q37737548 | Management of prostate cancer in HIV-positive patients |
| Q55035696 | Merkel cell carcinoma and HIV infection. |
| Q43297979 | Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion |
| Q38074154 | Modulation of immunity by antiangiogenic molecules in cancer |
| Q36513575 | Molecular pathogenesis of Hodgkin lymphoma |
| Q35233148 | Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy |
| Q33898621 | Mortality by causes in HIV-infected adults: comparison with the general population. |
| Q38140679 | Mutations in components of antiviral or microbial defense as a basis for breast cancer. |
| Q45730450 | Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus |
| Q37137430 | New Approaches to Immunotherapy for HPV Associated Cancers |
| Q58576103 | Next-Generation Modeling of Human Cancers |
| Q81679215 | Non-AIDS-Defining Cancers and HIV Infection |
| Q37838813 | Non-AIDS-Defining Malignancies in Patients with HIV in the HAART Era. |
| Q33859370 | Non-AIDS-Defining Malignancies in the HIV-Infected Population |
| Q30960546 | Non-AIDS-defining cancer in HIV-infected people. |
| Q38112573 | Non-AIDS-defining cancers among HIV-infected patients |
| Q36223928 | Non-AIDS-defining cancers and HIV infection |
| Q38084785 | Non-AIDS-defining cancers in New Orleans |
| Q37216892 | Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era. |
| Q37180845 | Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities |
| Q38673153 | Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group |
| Q45937838 | Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter −592 C/C genotype |
| Q45373956 | Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan. |
| Q38463130 | Noncancer causes of death in survivors of testicular cancer |
| Q34564288 | Noninfectious pulmonary complications of human immunodeficiency virus infection |
| Q37101017 | Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. |
| Q91784691 | Obesity, Metabolic Syndrome, and Breast Cancer: From Prevention to Intervention |
| Q26782741 | Oculocutaneous Albinism and Squamous Cell Carcinoma of the Skin of the Head and Neck in Sub-Saharan Africa |
| Q35026841 | Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated |
| Q36693871 | Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy |
| Q36177569 | Opportunistic intestinal infections and risk of colorectal cancer among people with AIDS. |
| Q34407889 | Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature |
| Q34521587 | Oral lesions of HIV disease and HAART in industrialized countries |
| Q43571985 | Oral squamous cell carcinoma in human immunodeficiency virus positive patients: clinicopathological audit |
| Q38067660 | Organ Transplantation and HIV Progress or Success? A Review of Current Status |
| Q36729134 | Osteosarcoma in Adult Patients Living with HIV/AIDS |
| Q36694972 | Outcome of patients with HIV-related germ cell tumours: a case-control study. |
| Q37649991 | Outcomes and chemotherapy-related toxicity in HIV-infected patients with breast cancer |
| Q37256940 | Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection. |
| Q33870809 | Pap test and HIV testing behaviors of South Carolina women 18-64 years old. |
| Q29614305 | Paradoxical roles of the immune system during cancer development |
| Q35110909 | Pathogenesis and manifestations of human herpesvirus-8-associated disorders |
| Q38496608 | Perforin and granzymes: function, dysfunction and human pathology |
| Q40110968 | Plasma Cell Disorders in HIV Infected Patients: A Case Series |
| Q34256144 | Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms |
| Q30994410 | Plasma cell tumors in HIV-positive patients: report of a case and review of the literature |
| Q81511143 | Plasmablastic lymphoma of the oral cavity in an HIV-positive child |
| Q62092391 | Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features |
| Q45722520 | Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. |
| Q37080479 | Prevalence of Anal HPV Infection Among HIV-Positive Men Who Have Sex With Men in India |
| Q37624009 | Prevalence of HIV Infection among U.S. Hodgkin lymphoma cases |
| Q39004098 | Prevalence of and risk factors for penile infection by high-risk human papillomavirus among men infected with HIV. |
| Q42259971 | Preventive cancer screening practices in HIV-positive patients |
| Q37718621 | Primary central nervous system lymphoma in an human immunodeficiency virus-infected patient mimicking bilateral eye sign in brain seen in fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography |
| Q46391747 | Primary squamous cell carcinoma of Stensen's duct in a patient with HIV: the role of magnetic resonance imaging and fine-needle aspiration |
| Q34875021 | Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome |
| Q34139859 | Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies |
| Q36285986 | Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies |
| Q41467577 | Promising Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Human Immunodeficiency Virus Associated Non-Hodgkin's Lymphoma |
| Q37538520 | Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. |
| Q33623439 | Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers |
| Q92126108 | Prostate cancer in sexual minorities and the influence of HIV status |
| Q35829970 | Prostate carcinoma among men with human immunodeficiency virus infection |
| Q36132370 | Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary? |
| Q36278045 | Recombinant human growth hormone therapy in HIV-associated wasting and visceral adiposity |
| Q34292990 | Reduced Risk of Prostate Cancer in U.S. Men with AIDS |
| Q37051177 | Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review |
| Q57877211 | Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies |
| Q35220992 | Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women |
| Q37247180 | Review: the need for smoking cessation among HIV-positive smokers |
| Q30491585 | Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis |
| Q45363060 | Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia |
| Q35758895 | Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults |
| Q38425202 | Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. |
| Q52660669 | Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States. |
| Q36612286 | Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. |
| Q36670737 | Risk of cancer in persons with AIDS in Italy, 1985-1998. |
| Q37309962 | Risk of human papillomavirus-associated cancers among persons with AIDS. |
| Q35150769 | Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies. |
| Q30592352 | Risk of myeloid neoplasms after solid organ transplantation |
| Q34158436 | Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort |
| Q57055334 | Roles of the immune system in cancer: from tumor initiation to metastatic progression |
| Q33759475 | Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States |
| Q40226043 | Same-sex marriage, autoimmune thyroid gland dysfunction and other autoimmune diseases in Denmark 1989-2008. |
| Q34539035 | Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review |
| Q33965744 | Season of birth and risk for adult onset glioma |
| Q36842166 | Short communication: lack of occult HIV infection among non-AIDS-defining cancer patients in three academic oncology clinics in the United States |
| Q64065570 | Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS |
| Q38124737 | Solid organ transplants in HIV-infected patients |
| Q37367685 | Spectrum of AIDS defining & non-AIDS defining malignancies in north India |
| Q34064264 | Spectrum of cancer risk late after AIDS onset in the United States. |
| Q92172776 | Spectrum of malignancies among the population of adults living with HIV infection in China: A nationwide follow-up study, 2008-2011 |
| Q37007011 | Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients |
| Q37793405 | Stem cell transplantation for lymphoma patients with HIV infection |
| Q38388988 | Strategies for Oral Health Research in Africa and the Middle Eastern Region |
| Q47123925 | Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma |
| Q45640458 | Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease |
| Q34477808 | Survival Patterns in Patients With Hodgkin's Lymphoma With a Pre-Existing Hospital Discharge Diagnosis of Autoimmune Disease |
| Q38130185 | Testicular cancer and viral infections: a systematic literature review and meta-analysis |
| Q24645142 | Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm? |
| Q34513248 | Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States |
| Q27486618 | The Role of Infectious Agents in the Etiology of Ocular Adnexal Neoplasia |
| Q39339439 | The Role of Nuclear Medicine in the Staging and Management of Human Immune Deficiency Virus Infection and Associated Diseases |
| Q46142571 | The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic. |
| Q56946062 | The association of human immunodeficiency virus and skeletal metastases in breast cancer using Tc-99m methyl diphosphonate bone scan |
| Q33610431 | The association of neoplasms and HIV infection in the correctional setting |
| Q33523293 | The challenge of AIDS-related malignancies in sub-Saharan Africa |
| Q35552875 | The changing pattern of ano-rectal cancer, squamous cell carcinoma of the eye, and Hodgkin's lymphoma as non-AIDS-defining cancers, by HIV status, in Tanzania over 11 years (2002-2012): a retrospective case-report study |
| Q34952990 | The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry |
| Q37222094 | The essentials of HIV: a review for nurses |
| Q36544543 | The evolution of the population-based cancer registry |
| Q34648354 | The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts |
| Q37287616 | The impact of nelfinavir exposure on cancer development among a large cohort of HIV-infected patients |
| Q93160616 | The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review |
| Q34661971 | The multitude and diversity of environmental carcinogens |
| Q58033178 | The pattern of excess cancer in dialysis and transplantation |
| Q59364595 | The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance |
| Q36615747 | The risk of cancer in HIV-infected people in southeast England: a cohort study |
| Q38069126 | The role of human papillomavirus in nongenital cancers |
| Q36111103 | The role of primary care physicians in improving colorectal cancer screening in patients with HIV. |
| Q22251070 | Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and management |
| Q36117996 | Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice? |
| Q35178632 | Time for oncologists to opt in for routine opt-out HIV testing? |
| Q35917538 | Treatment of HIV infection in the older patient |
| Q35841817 | Treatment of chronic lymphocytic leukemia with bendamustine in an HIV-infected patient on antiretroviral therapy: a case report and review of the literature |
| Q58975060 | Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002 |
| Q40259517 | Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area |
| Q80885817 | Trends in the incidence of acquired immunodeficiency syndrome-related malignancies in Thailand |
| Q37305792 | Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study |
| Q38486286 | Trends in the incidence of testicular germ cell tumors in the United States |
| Q34918218 | Urologic complications of HIV and AIDS. |
| Q39080596 | Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs. |
| Q34170074 | Vaccines and immunotherapeutics for the treatment of malignant disease |
| Q33375306 | Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil |
| Q39002759 | Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer. |
| Q77688948 | [GESIDA/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients] |
| Q79227689 | [HIV-associated tumors] |
| Q80737386 | [Lung cancer in HIV-positive patients] |